Keywords: FKD Therapies, Merck & Co, Gene therapy portfolio, Bladder cancer

Newly-formed FKD Therapies gets rights to Merck & Co gene therapy portfolio

Article | 22 September 2011

Print This

FKD Therapies Oy, a recently-formed company in Finland specializing in advanced gene based medicines, has acquired an exclusive licence from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in